Legal Opinion
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided March 31, 2008No. 2007-1223PublishedCited by 132 opinions
1Opinion of the Court
RADER, Circuit Judge.
The United States District Court for the District of New Jersey permanently enjoined Mylan Laboratories, Inc. from infringing Ortho-McNeil Pharmaceutical Inc.’s U.S. Patent No. 4,513,006 (’006). The '006 patent claims the anticonvulsive drug topiramate. The trial court also reset the effective approval date for Mylan’s Abbreviated New Drug Application (ANDA). Because the district court correctly ruled on claim construction, inequitable conduct, obviousness, and enablement, and because the district court did not err in resetting the effective date of Mylan’s ANDA under 35…
2Cases cited15 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
10 more not listed; retrieve them via the Exa API.
3Cited by132 opinions
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
- Crocs, Inc. v. International Trade CommissionCourt of Appeals for the Federal Circuit · 2010
- Kinetic Concepts, Inc. v. Smith & Nephew, Inc.Court of Appeals for the Federal Circuit · 2012
- Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2014
- In Re KubinCourt of Appeals for the Federal Circuit · 2009
127 more not listed; retrieve them via the Exa API.